Company / R&D per Share
VOLITIONRX LTD R&D per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.15
FY2025
5-year range
$0.15 / $0.30
FY2021-FY2025
Trend
-37.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.15 in FY2025 to $0.31 in FY2019.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of -9.9%.
Declined from $0.26 to $0.15 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- -9.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 37.2% year-over-year.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | -37.2% |
| FY2024 | $0.24 | -9.9% |
| FY2023 | $0.26 | +9.4% |
| FY2022 | $0.24 | -19.0% |
| FY2021 | $0.30 | +18.7% |
| FY2020 | $0.25 | -18.4% |
| FY2019 | $0.31 | +44.0% |
| FY2014 | $0.21 | -21.2% |
| FY2013 | $0.27 | +54.7% |
| FY2012 | $0.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026